THE TOXIC EFFECT OF SILIBININ AND PACLITAXEL COMBINATION ON ENDOMETRIAL CANCER CELL LINE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BASIRI A.; PASHAIASL M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS) Year:2016 | Volume:16 | Issue:3 Page(s): 323-330

Download Full-Text

Persian Verion

View:

967

Download:

Cites:

Information Journal Paper

Title

THE TOXIC EFFECT OF SILIBININ AND PACLITAXEL COMBINATION ON ENDOMETRIAL CANCER CELL LINE

Author(s)

BASIRI A. | PASHAIASL M. | Issue Writer Certificate

Keywords

ENDOMETRIAL CANCERQ3

PACLITAXELQ1

SILIBININQ1

CYTOTOXICITYQ2

Abstract

Background & objectives: Among gynecologic malignancies, ENDOMETRIAL CANCER is the fourth most frequent cause of cancer death all over the world. PACLITAXEL is one of the chemotherapy regimens that is used against this cancer. Treatment of tumor with PACLITAXEL induces apoptosis, but it is also associated with serious side effects. Thus, it is imperative to search for more effective and safer chemotherapeutic regimens. SILIBININ is a milk thistle plant extract that its antioxidant effects against some cancers have been studied. The aim of this study was to examine the effect of PACLITAXEL and SILIBININ combination on ENDOMETRIAL CANCER cell line (Hela).Methods: Hela cell line was cultured in 25cm2 flask in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS). Then the numbers of live cells were calculated with trypan blue staining method and then the cells were seeded in to 96-well flat-bottomed culture plates and treated with Silibilin, PACLITAXEL and PACLITAXEL plus Silibilin together with the control without treatment. MTT assay was used to evaluate CYTOTOXICITY of different treatments.Results: After 48 hours of treatment, PACLITAXEL and Silibilin combination inhibited cell growth significantly compared with the other groups (p<0.05).Conclusions: It is indicated that combination of PACLITAXEL and Silibilin can affect the growth arrest of Hela cancer cell line more effective than other treatments and is needed to be examined in vitro.

Cites

No record.

References

Cite

APA: Copy

BASIRI, A., & PASHAIASL, M.. (2016). THE TOXIC EFFECT OF SILIBININ AND PACLITAXEL COMBINATION ON ENDOMETRIAL CANCER CELL LINE. JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS), 16(3), 323-330. SID. https://sid.ir/paper/59834/en

Vancouver: Copy

BASIRI A., PASHAIASL M.. THE TOXIC EFFECT OF SILIBININ AND PACLITAXEL COMBINATION ON ENDOMETRIAL CANCER CELL LINE. JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS)[Internet]. 2016;16(3):323-330. Available from: https://sid.ir/paper/59834/en

IEEE: Copy

A. BASIRI, and M. PASHAIASL, “THE TOXIC EFFECT OF SILIBININ AND PACLITAXEL COMBINATION ON ENDOMETRIAL CANCER CELL LINE,” JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS), vol. 16, no. 3, pp. 323–330, 2016, [Online]. Available: https://sid.ir/paper/59834/en

Related Journal Papers